Canada Pharmaceuticals

Curaleaf Holdings Inc (CURA)

Track

Track

Curaleaf Holdings Inc. experienced nineteen insider trading transactions recently, totaling over 1.1 million dollars in sales versus roughly 197,000 dollars in purchases. Senior officer Peter Clateman executed multiple planned trades, while director Karl Johansson sold shares. These activities follow a positive earnings report where the company exceeded expectations by 129 percent.
Ticker: CURA Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Curaleaf Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
321.66
Quantity 83,916 -21.4%
Value US$76,626
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
214.22
Quantity 48,118 -5.9%
Value US$1,354,717
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
29.47
Quantity 66,334 -7.2%
Value US$4,187,079
Johansson, Karl Director of Issuer Non-Executive Director
Transaction date
Sale
Price
9.59
Quantity 39,000 -25.9%
Value US$373,940
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
9.43
Quantity 3,334 -0.6%
Value US$31,440
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
9.43
Quantity 10,000 -1.9%
Value US$94,339
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
1.48
Quantity 22,223 +4.4%
Value US$32,861
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
9.17
Quantity 3,334 -0.7%
Value US$30,576
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
9.22
Quantity 10,000 -1.9%
Value US$92,197
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
1.48
Quantity 22,223 +4.5%
Value US$32,861
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
8.29
Quantity 3,334 -0.7%
Value US$27,648
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
8.24
Quantity 10,000 -2.0%
Value US$82,363
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
1.48
Quantity 22,223 +4.6%
Value US$32,861
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
9.67
Quantity 3,334 -0.7%
Value US$32,240
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
9.67
Quantity 10,000 -2.0%
Value US$96,661
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
1.48
Quantity 22,223 +4.7%
Value US$32,861
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
9.97
Quantity 3,334 -0.7%
Value US$33,240
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned sale
Price
10.03
Quantity 10,000 -2.1%
Value US$100,260
2.0
Clateman, Peter Laurence Senior Officer of Issuer Officer
Transaction date
Planned purchase
Price
1.48
Quantity 22,223 +4.8%
Value US$32,861
Pinto, Rahul Senior Officer of Issuer Officer
Transaction date
Sale
Price
9.23
Quantity 82,452 -49.0%
Value US$760,620
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-14 2026-09-09 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
83,916 -21.4%
321.66
US$76,626 		83,916 -21.4% 321.66 US$76,626
2026-09-14 2026-09-09 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
48,118 -5.9%
214.22
US$1,354,717 		48,118 -5.9% 214.22 US$1,354,717
2026-09-14 2026-09-09 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
66,334 -7.2%
29.47
US$4,187,079 		66,334 -7.2% 29.47 US$4,187,079
2026-09-09 2026-09-03 S Sale
Johansson, Karl

Director of Issuer

Non-Executive Director
39,000 -25.9%
9.59
US$373,940 		39,000 -25.9% 9.59 US$373,940
2026-08-28 2026-08-26 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
3,334 -0.6%
9.43
US$31,440 		3,334 -0.6% 9.43 US$31,440
2026-08-28 2026-08-26 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
10,000 -1.9%
9.43
US$94,339 		10,000 -1.9% 9.43 US$94,339
2026-08-28 2026-08-26 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
22,223 +4.4%
1.48
US$32,861 		22,223 +4.4% 1.48 US$32,861
2026-08-19 2026-08-14 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
3,334 -0.7%
9.17
US$30,576 		3,334 -0.7% 9.17 US$30,576
2026-08-19 2026-08-14 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
10,000 -1.9%
9.22
US$92,197 		10,000 -1.9% 9.22 US$92,197
2026-08-19 2026-08-14 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
22,223 +4.5%
1.48
US$32,861 		22,223 +4.5% 1.48 US$32,861
2026-08-03 2026-07-29 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
3,334 -0.7%
8.29
US$27,648 		3,334 -0.7% 8.29 US$27,648
2026-08-03 2026-07-29 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
10,000 -2.0%
8.24
US$82,363 		10,000 -2.0% 8.24 US$82,363
2026-08-03 2026-07-29 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
22,223 +4.6%
1.48
US$32,861 		22,223 +4.6% 1.48 US$32,861
2026-07-17 2026-07-15 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
3,334 -0.7%
9.67
US$32,240 		3,334 -0.7% 9.67 US$32,240
2026-07-17 2026-07-15 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
10,000 -2.0%
9.67
US$96,661 		10,000 -2.0% 9.67 US$96,661
2026-07-17 2026-07-15 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
22,223 +4.7%
1.48
US$32,861 		22,223 +4.7% 1.48 US$32,861
2026-07-06 2026-07-01 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
3,334 -0.7%
9.97
US$33,240 		3,334 -0.7% 9.97 US$33,240
2026-07-06 2026-07-01 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
10,000 -2.1%
10.03
US$100,260 		10,000 -2.1% 10.03 US$100,260
2026-07-06 2026-07-01 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
22,223 +4.8%
1.48
US$32,861 		22,223 +4.8% 1.48 US$32,861
2026-06-26 2026-06-24 S Sale
Pinto, Rahul

Senior Officer of Issuer

Officer
82,452 -49.0%
9.23
US$760,620 		82,452 -49.0% 9.23 US$760,620
Explore more

More insider trading research around Curaleaf Holdings Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America